Lyterian

Lysosomal Therapeutics

This biotechnology firm develops small-molecule therapies for patients with neurodegenerative conditions such as Parkinson's disease and other lysosomal storage disorders.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Mair Therapeutics

This biotechnology company develops small-molecule therapeutics targeting lysosomal ion channels for patients with neurodegenerative conditions such as Parkinson’s disease.

Tactile Therapeutics

This company develops small molecule drugs using targeted protein degradation to treat neurodegenerative diseases and cancer for pharmaceutical partners and patients.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Mair Therapeutics

This biotechnology company develops small-molecule therapies targeting lysosomal ion channels to treat neurodegenerative disorders such as Parkinson's disease for patients and healthcare institutions.

Trimtech Therapeutics

This biotechnology company develops small molecule drugs that target and degrade toxic protein aggregates to treat neurodegenerative and inflammatory diseases.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.